
NICE has published draft guidance which does not recommend Stelara (ustekinumab) for treating moderately to severely active ulcerative colitis in …

A team of biomedical scientists at the University of California has found that a FDA-approved drug for treating rheumatoid arthritis …

Death rates for breast, bowel, lung and prostate cancer combined have fallen by almost a third in the last 20 …

When French pharmaceutical company Sanofi announced the appointment of Dr Anne Beal as chief patient officer in late March, the …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

